CONTENTS
Issue 89 | December 2019
![](/pharma/pharma_dec19/contents/763819/1_flu_content.480_0_1.jpg)
Influenza affects thousands each year, but how has the flu jab helped stop the spread?
![](/pharma/pharma_dec19/contents/763828/content.480_0_1.jpg)
Children are being prescribed medicines that have only been tested on adults
![](/pharma/pharma_dec19/contents/763821/3_art_content.480_0_1.jpg)
Should countries break the China/ India API monopoly be repatriating manufacturing?
![](/pharma/pharma_dec19/contents/763822/4_art_content.480_0_1.jpg)
Inside the lean, green, drug manufacturing machine established in Ireland
![](/pharma/pharma_dec19/contents/763823/5_art_content.480_0_1.jpg)
Could there be a simple cure to prevent recurrent misscarriage?
![](/pharma/pharma_dec19/contents/763824/6_art_content.480_0_1.jpg)
Pharma's reputation isn't great , so how can PR help to fix the industry's image problem?
![](/pharma/pharma_dec19/contents/763825/7_art_content.480_0_1.jpg)
The Gavi alliance is working to support the immunisation of 300 million people
![](/pharma/pharma_dec19/contents/763826/8_art_content.480_0_1.jpg)
Research suggests that pivotal trials of new cancer drugs are at high risk of bias